{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:33:47Z","timestamp":1792802027755,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2002,4]]},"DOI":"10.1038\/sj.bjc.6600247","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T15:08:05Z","timestamp":1031152085000},"page":"1243-1249","source":"Crossref","is-referenced-by-count":93,"title":["The level of haemoglobin in anaemic cancer patients correlates positively with quality of life"],"prefix":"10.1038","volume":"86","author":[{"given":"M","family":"Lind","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Vernon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Cruickshank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Littlewood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Jenkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Grey-Amante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Doll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Wild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2002,4,16]]},"reference":[{"key":"BF6600247_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1159\/000204780","volume":"87","author":"RI Abels","year":"1992","unstructured":"Abels RI (1992) Recombinant human erythropoietin in the treatment of anaemia of cancer. Acta Haematologica 87: 4\u201311","journal-title":"Acta Haematologica"},{"key":"BF6600247_CR2","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/S0959-8049(05)80281-3","volume":"29A","author":"RI Abels","year":"1993","unstructured":"Abels RI (1993) Erythropoietin for anaemia in cancer patients. Eur J Cancer 29A: S2\u2013S8","journal-title":"Eur J Cancer"},{"key":"BF6600247_CR3","first-page":"121","volume-title":"Blood Cell Growth Factors: Their Present and Future Use in Hematology and Oncology","author":"RI Abels","year":"1991","unstructured":"Abels RI, Larholt KM, Krantz KD, Bryant EC (1991) Recombinant human erythropoietin (r-HuEPO) for the treatment of the anemia of cancer. Proceedings of the Beijing Symposium. In Blood Cell Growth Factors: Their Present and Future Use in Hematology and Oncology Murphy Jr MJ (ed) pp 121\u2013141, Dayton, Ohio: AlphaMed Press"},{"key":"BF6600247_CR4","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1159\/000011929","volume":"56","author":"JW Adamson","year":"1999","unstructured":"Adamson JW, Ludwig H (1999) Predicting the hematopoietic response to recombinant human erythropoietin (epoetin alfa) in the treatment of anemia of cancer. Oncology 56: 46\u201353","journal-title":"Oncology"},{"key":"BF6600247_CR5","doi-asserted-by":"publisher","first-page":"269","DOI":"10.2165\/00002018-199819040-00003","volume":"19","author":"Y Beguin","year":"1998","unstructured":"Beguin Y (1998) A risk-benefit assessment of Epoetin in the management of anaemia associated with cancer. Drug Safety 19: 269\u2013282","journal-title":"Drug Safety"},{"key":"BF6600247_CR6","volume-title":"Measuring Health: A review of quality of life measurement scales","author":"A Bowling","year":"1991","unstructured":"Bowling A (1991) Measuring Health: A review of quality of life measurement scales Philadelphia: Open University Press"},{"key":"BF6600247_CR7","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1093\/jnci\/85.10.801","volume":"85","author":"DC Case","year":"1993","unstructured":"Case DC, Bukowski RM, Carey RW, Fishkin EH, Henry DH, Jacobson RJ, Jones SE, Keller AM, Kugler JW, Nichols CR, Salmon SE, Silver RT, Storniolo AM, Wampler GL, Dooley CM, Larholt KM, Nelson RA, Abels RI (1993) Recombinant human erythropoietin therapy for anaemic cancer patients on combination chemotherapy. J Natl Cancer Inst 85: 801\u2013806","journal-title":"J Natl Cancer Inst"},{"key":"BF6600247_CR8","unstructured":"Cella D (1997a) F.A.C.I.T. Manual: Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) scales Version 4, Center on Outcomes, Research and Education (CORE), Evanston, IL: Evanston Northwestern Healthcare and Northwestern University"},{"key":"BF6600247_CR9","first-page":"13","volume":"34","author":"D Cella","year":"1997","unstructured":"Cella D (1997b) The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: A new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Haematol 34: 13\u201319","journal-title":"Semin Haematol"},{"key":"BF6600247_CR10","first-page":"43","volume":"25","author":"D Cella","year":"1998","unstructured":"Cella D (1998) Factors influencing quality of life in cancer patients: Anemia and fatigue. Semin Oncol 25: 43\u201346","journal-title":"Semin Oncol"},{"key":"BF6600247_CR11","volume-title":"Quality of Life and Pharmacoeconomics in Clinical Trials","author":"DF Cella","year":"1996","unstructured":"Cella DF, Bonomi AE (1996) The Functional Assessment of Cancer Therapy (FACT) and Functional Assessment of HIV Infection (FAHI) quality of life measurement system. In Quality of Life and Pharmacoeconomics in Clinical Trials 2nd ed Spilker B (ed) Philadelphia: Lippincott-Raven"},{"key":"BF6600247_CR12","first-page":"232","volume":"11","author":"D Cella","year":"1997","unstructured":"Cella D, Webster K (1997) Linking outcomes management to quality-of-life measurement. Oncology 11: 232\u2013235","journal-title":"Oncology"},{"key":"BF6600247_CR13","volume-title":"Identifying hemoglobin level for optimal quality of life: Results of an incremental analysis","author":"CS Cleeland","year":"1999","unstructured":"Cleeland CS, Demetri GD, Glaspy J, Cella DF, Portenoy RK, Cremieux P-Y, Itri LM (1999) Identifying hemoglobin level for optimal quality of life: Results of an incremental analysis Proceedings of ASCO, Vol 18 Symptom Management (abstract No. 2215)"},{"key":"BF6600247_CR14","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1200\/JCO.1998.16.10.3412","volume":"16","author":"GD Demetri","year":"1998","unstructured":"Demetri GD, Kris M, Wade J, Degos L, Cella D (1998) Quality-of-life benefit in chemotherapy patients treated with Epoetin Alfa is independent of disease response or tumour type: Results from a prospective community oncology study. J Clin Oncol 16: 3412\u20133425","journal-title":"J Clin Oncol"},{"key":"BF6600247_CR15","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1200\/JCO.1997.15.3.1218","volume":"15","author":"J Glaspy","year":"1997","unstructured":"Glaspy J, Bukowski R, Steinberg D, Taylor C, Tchekmedyian S, Vadhan-Raj S (1997) Impact of therapy with Epoetin Alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. J Clin Oncol 15: 1218\u20131234","journal-title":"J Clin Oncol"},{"key":"BF6600247_CR16","volume-title":"Assessment and Evaluation of Health and Medical Care","author":"R Layte","year":"1997","unstructured":"Layte R, Jenkinson C (1997) Social Surveys. In Assessment and Evaluation of Health and Medical Care Jenkinson C (ed) Buckingham: Open University Press"},{"key":"BF6600247_CR17","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1002\/1097-0142(19940515)73:10<2535::AID-CNCR2820731014>3.0.CO;2-5","volume":"73","author":"C Leitgeb","year":"1994","unstructured":"Leitgeb C, Pecherstorfer M, Fritz E, Ludwig H (1994) Quality of life in chronic anemia of cancer during treatment with recombinant human erythropoietin. Cancer 73: 2535\u20132542","journal-title":"Cancer"},{"key":"BF6600247_CR18","volume-title":"Proceedings of ASCO, Vol 18","author":"TJ Littlewood","year":"1998","unstructured":"Littlewood TJ, Bajetta E, Cella D (1998) Efficacy and quality of life outcomes of Epoetin Alfa in a double-blind, placebo-controlled mulitcenter study of cancer patients receiving non-platinum containing chemotherapy. Proceedings of ASCO, Vol 18 Symptom Management (abstract No. 2217)"},{"key":"BF6600247_CR19","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/oxfordjournals.annonc.a058423","volume":"4","author":"H Ludwig","year":"1993","unstructured":"Ludwig H, Fritz E, Leitgeb C, Krainer M, K\u00fchrer I, Sagaster P, Umek H (1993) Erythropoietin treatment for chronic anemia of selected haematological malignancies and solid tumours. Ann Oncol 4: 161\u2013167","journal-title":"Ann Oncol"},{"key":"BF6600247_CR20","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1002\/1097-0142(19951201)76:11<2319::AID-CNCR2820761121>3.0.CO;2-U","volume":"76","author":"H Ludwig","year":"1995","unstructured":"Ludwig H, Sundal E, Pecherstorfer M, Leitgeb C, Bauernhofer T, Beinhauer A, Samonigg H, Kappeler AW, Fritz E (1995) Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy. Cancer 76: 2319\u20132329","journal-title":"Cancer"},{"key":"BF6600247_CR21","first-page":"127","volume":"48","author":"IA Malik","year":"1998","unstructured":"Malik IA, Khan ZK, Hakimali A, Sabih M, Rehman G (1998) The effect of subcutaneous recombinant human erythropoietin (r-HuEPO) on anemia in cancer patients receiving platinum-based chemotherapy. JPMA 48: 127\u2013131","journal-title":"JPMA"},{"key":"BF6600247_CR22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/00005650-199401000-00004","volume":"32","author":"CA McHorney","year":"1994","unstructured":"McHorney CA, Ware JE, Lu JFR (1994) The MOS 36-item Short-Form Health Survey (SF-36): III Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Medical Care 32: 40\u201366","journal-title":"Medical Care"},{"key":"BF6600247_CR23","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1159\/000203625","volume":"98","author":"M Mittelman","year":"1997","unstructured":"Mittelman M, Zeidman A, Fradin Z, Magazanik A, Lewinski UH, Cohen A (1997) Recombinant human erythropoietin in the treatment of multiple myeloma-associated anemia. Acta Haematologica 98: 204\u2013210","journal-title":"Acta Haematologica"},{"key":"BF6600247_CR24","volume-title":"Quality of Life Assessments in Clinical Trials","author":"B Spilker","year":"1990","unstructured":"Spilker B (1990) Quality of Life Assessments in Clinical Trials New York: Raven Press"},{"key":"BF6600247_CR25","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1038\/bjc.1998.331","volume":"77","author":"PJ Sweeney","year":"1998","unstructured":"Sweeney PJ, Nicolae D, Ignacio L, Chen L, Roach III M, Wara W, Marcus KC, Vijayakumar S (1998) Effect of subcutaneous recombinant human erythropoetin in cancer patients receiving radiotherapy: Final report of a randomised, open-labelled, phase II trial. Br J Cancer 77: 1996\u20132002","journal-title":"Br J Cancer"},{"key":"BF6600247_CR26","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/0360-3016(93)90299-B","volume":"26","author":"S Vijayakumar","year":"1993","unstructured":"Vijayakumar S, Roach III M, Wara W, Chan SK, Ewing C, Rubin S, Sutton H, Halpern H, Awan A, Houghton A, Quiet C, Weichselbaum R (1993) Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: Preliminary results of a randomised, open-labelled, phase II trial. Int J Radiation Oncology Biol Phys 26: 721\u2013729","journal-title":"Int J Radiation Oncology Biol Phys"},{"key":"BF6600247_CR27","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware","year":"1992","unstructured":"Ware JE, Sherborne CD (1992) The MOS 36-item Short Form Health Survey (SF-36): I. Conceptual framework and item selection. Medical Care 30: 473\u2013483","journal-title":"Medical Care"},{"key":"BF6600247_CR28","first-page":"23","volume":"21","author":"ML Winningham","year":"1994","unstructured":"Winningham ML, Nail LM, Burke MB et al (1994) Fatigue and the cancer experience: The state of the knowledge. Oncol Nurs Forum 21: 23\u201326","journal-title":"Oncol Nurs Forum"},{"key":"BF6600247_CR29","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0885-3924(96)00274-6","volume":"13","author":"SB Yellen","year":"1997","unstructured":"Yellen SB, Cella DF, Webster K, Bledowski C, Kaplan E (1997) Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 13: 63\u201374","journal-title":"J Pain Symptom Manage"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6600247.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6600247","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6600247.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:42:16Z","timestamp":1684413736000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6600247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2002,4]]}},"alternative-id":["BF6600247"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6600247","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,4]]}}}